-
Feb 05 |
Diagnostics World | Physiological changes in the body driven by inflammation, as happens with inflammatory bowel disease (IBD) and rheumatoid arthritis, can be “easily and passively” measured with commercially available wearable devices, according to gastroenterologist Robert Hirten, M.D., associate professor of medicine and artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai.
More
-
Feb 04 |
Diagnostics World | Amid an industrywide shortage of workers and hospital capacity, a multimodal artificial intelligence (AI) platform providing real-time visibility into the clinical picture for patients is finding a national audience with health systems big and small who want to “make the right thing the easy thing to do” for their overburdened clinicians.
More
-
Jan 29 |
Diagnostics World | January’s funding focused on at-home cancer diagnostics, treatments for autoimmune disorders, and gene therapy for ophthalmology, Hepatitis B, and more.
More
-
Jan 28 |
Diagnostics World News | PathAI and Discovery Life Sciences launch partnership; new diagnostic tools for epilepsy, syphilis; OGT launches MRD panel; more.
More
-
Jan 23 |
Diagnostics World | At this year’s J.P. Morgan Healthcare Conference, Masoud Toloue, CEO of Quanterix, presented his company’s achievements of 2024, the acquisition of Akoya Biosciences, and their plans for the new year. Toloue opened with Quanterix’s mission, “The mission at Quanterix is to create the tools to enable discovery and better health.”
More
-
Jan 22 |
Diagnostics World | Researchers at the Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSKCC), have unveiled SCORPIO, an artificial intelligence (AI) tool designed to predict cancer patients’ responses to immune checkpoint inhibitor (ICI) therapy. By focusing on diagnostic capabilities, SCORPIO uses routine blood tests and clinical data to identify patterns that correlate with treatment outcomes, offering an innovative approach to guiding immunotherapy decisions.
More
-
Jan 21 |
Diagnostics World | PacBio’s president Christian Henry gave the sequencing company’s 43rd Annual J.P. Morgan Healthcare Conference address last week. And while Oxford Nanopore and Illumina both doubled down on proteomics and a multi-omic future, Henry stayed focus on PacBio’s mission to enable the promise of genomics to better human health.
More
-
Jan 15 |
Diagnostics World | Grail presented for the first time at the 42rd Annual J.P. Morgan Healthcare conference today, and Bob Ragusa, CEO, took the stage. Grail was divested from Illumina and became an independent, publicly traded company in June 2024. But while the company structure has changed significantly in 2024, the mission has not, Ragusa said: detecting cancer early, when it can be cured.
More
-
Jan 13 |
Diagnostics World | Among the many partnerships and technical announcements made by NVIDIA during the company's Monday morning presentation at the 43rd Annual J.P. Morgan Healthcare Conference, NVIDIA focused several on innovation within the healthcare and life sciences industry.
More
-
Jan 09 |
Diagnostics World | In the next phase of breath diagnostics, there is a promising area for future research: expanding upon the notion of “breath diagnostics” to leverage volatile organic compounds (VOCs) from elsewhere. VOCs from urine could be used to detect prostate cancer, for example. If looked at carefully with the right AI tools, leveraging VOCs could lead to compelling healthcare solutions down the road.
More
-
Feb 03 |
More
-
Feb 03 |
Christine Eng, M.D., chief medical officer and chief quality officer at Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will present on new RNA sequencing insights for rare disease as part of the Clinical Dx (Diagnostic) Showcase track at the Precision Medicine World Conference (PMWC) 2025.
More
-
Feb 03 |
More
-
Feb 03 |
Ultra-low variant detection (including very large FLT3-ITDs) by OGT's new SureSeq™ Myeloid MRD Panel enables a stronger characterization of a sample’s current AML status
More
-
Feb 03 |
Pharmapack Europe 2025 proudly announces the winners of its newly reformatted Pharmapack Awards, recognising excellence across six transformative categories in pharmaceutical packaging and drug delivery. This year’s honourees include innovative advancements in sustainable materials, patient-centered design, and next-generation devices—all poised to redefine healthcare delivery.
Notable winners include SHL Medical’s Elexy™ reusable electromechanical autoinjector, Huhtamaki’s Omnilock™ Ultra PAPER for eco-friendly packaging, and Mitsubishi Gas Chemical’s OXYCAPT multilayer vial for gene therapy. The prestigious Woman of the Year Award celebrates Asmita Khanolkar of SMC Ltd. for her decades-long contributions to drug-device innovation.
More
-
Feb 03 |
At Pharmapack Europe 2025, six exceptional start-ups have been honoured with the prestigious ‘Heart of Pharma’ awards, recognising their groundbreaking contributions to drug delivery, packaging, and patient care. Selected from a competitive field of 26 innovators, these companies are transforming healthcare with technologies that promise to revolutionize industry standards.
The winners include innovations such as sustainable biofuel-powered electronics, patient-friendly nasal sprays, next-generation intradermal drug delivery devices, and breakthrough vial-filling systems. Representing global excellence, recipients hail from the U.S., UK, Ireland, France, and the DACH region. With over 6,000 attendees and 370 exhibitors, Pharmapack remains the must-attend event for pharma innovation. Don’t miss the chance to cover these transformative start-ups and their award-winning technologies.
More
-
Feb 03 |
* £500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis
* Programme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet need
More
-
Feb 03 |
More
-
Feb 03 |
Medix Biochemica has announced the acquisition of CANDOR Bioscience GmbH, which strengthens Medix Biochemica’s portfolio in critical raw materials for IVD and enhances its capability to support immunoassay developers across the world.
More
-
Jan 15 |
Ambience Healthcare, the leading AI platform for healthcare documentation, scribing, coding, CDI, and patient summaries, announced today a pilot study with St. Luke's Health System has resulted in a 25% reduction in clinician burnout and a nearly 23% increase in patient face time for clinicians.
More
View more articles